Roux-Lombard P - Search Results

1

Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk.

Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J, Suter PM. Borrelli E, et al. Crit Care Med. 1996 Mar;24(3):392-7. doi: 10.1097/00003246-199603000-00006. Crit Care Med. 1996. PMID: 8625625 Review.

2

Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation.

Chenaud C, Merlani PG, Roux-Lombard P, Burger D, Harbarth S, Luyasu S, Graf JD, Dayer JM, Ricou B. Chenaud C, et al. Crit Care Med. 2004 Mar;32(3):632-7. doi: 10.1097/01.ccm.0000114820.47460.0a. Crit Care Med. 2004. PMID: 15090939

3

Imbalance between tumour necrosis factor-alpha and soluble TNF receptor concentrations in severe meningococcaemia. The J5 Study Group.

Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H, Dayer JM. Girardin E, et al. Immunology. 1992 May;76(1):20-3. Immunology. 1992. PMID: 1321092 Free PMC article.

4

High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis.

Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer JM. Suter PM, et al. Am Rev Respir Dis. 1992 May;145(5):1016-22. doi: 10.1164/ajrccm/145.5.1016. Am Rev Respir Dis. 1992. PMID: 1586041

5

Tumour necrosis factor in neonatal listeriosis: a case report.

Girardin E, Berner M, Grau GE, Dayer JM, Roux-Lombard P, Suter S. Girardin E, et al. Eur J Pediatr. 1989 Jun;148(7):644-5. doi: 10.1007/BF00441521. Eur J Pediatr. 1989. PMID: 2744036

6

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Girardin E, Grau GE, Dayer JM, Roux-Lombard P, Lambert PH. Girardin E, et al. N Engl J Med. 1988 Aug 18;319(7):397-400. doi: 10.1056/NEJM198808183190703. N Engl J Med. 1988. PMID: 3135497

7

Could natural inhibitors of tumor necrosis factor-alpha modify the clinical course of fulminant meningococcemia?

Villard J, Roux-Lombard P, Hugli A, Dayer JM. Villard J, et al. Crit Care Med. 1993 Sep;21(9):1396-400. doi: 10.1097/00003246-199309000-00025. Crit Care Med. 1993. PMID: 8396525 No abstract available.

8

Serum cytokine changes in systemic vasculitis.

Grau GE, Roux-Lombard P, Gysler C, Lambert C, Lambert PH, Dayer JM, Guillevin L. Grau GE, et al. Immunology. 1989 Oct;68(2):196-8. Immunology. 1989. PMID: 2478451 Free PMC article.

9

Production of interleukin-1 (IL-1) and a specific IL-1 inhibitor during human monocyte-macrophage differentiation: influence of GM-CSF.

Roux-Lombard P, Modoux C, Dayer JM. Roux-Lombard P, et al. Cytokine. 1989 Nov;1(1):45-51. doi: 10.1016/1043-4666(89)91047-8. Cytokine. 1989. PMID: 2491504

10

Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.

Suter S, Schaad UB, Roux-Lombard P, Girardin E, Grau G, Dayer JM. Suter S, et al. Am Rev Respir Dis. 1989 Dec;140(6):1640-4. doi: 10.1164/ajrccm/140.6.1640. Am Rev Respir Dis. 1989. PMID: 2604293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters